SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-16-457616
Filing Date
2016-02-10
Accepted
2016-02-10 16:20:36
Documents
3
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP, L.P.TRV GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d107688dsc13g.htm SC 13G 115939
2 EX-24 d107688dex24.htm EX-24 4154
3 EX-99.1 d107688dex991.htm EX-99.1 7066
  Complete submission text file 0001193125-16-457616.txt   128831
Mailing Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116
Business Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116 617-859-3099
THIRD ROCK VENTURES LP (Filed by) CIK: 0001408591 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89140 | Film No.: 161405987
SIC: 2834 Pharmaceutical Preparations